| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from exercise of warrants | 10,698 | - |
| Payment for repurchase of convertible subordinated notes due 2025 | 25 | - |
| Net cash provided by (used in) financing activities | 12,272 | 1,430 |
| Net increase in cash and cash equivalents | 171,549 | 92,568 |
| Cash and cash equivalents at beginning of period | 304,964 | - |
| Cash and cash equivalents at end of period | 476,513 | - |
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)